Objective: Evaluation of the expression characteristics between vimentin reaction samples and histological type, histological grade, and pT stage of gastric adenocarcinoma at Hanoi Medical University Hospital in 2022-2023. Subjects and research methods: cross-sectional descriptive study, convenience sampling. Results: Vimentin expression ranged from light yellow to reddish-brown in the cytoplasm of tumor cells undergoing mesenchymal transition, appearing as granules or diffuse. The positive rate for vimentin marker was 21.1%, while the negative rate was 78.9%. Strong expression of vimentin was observed in 12.3% of cases, and weak expression was found in 8.8%. The tubular adenocarcinoma type and poorly cohesive adenocarcinoma type each accounted for 19.3%; the papillary adenocarcinoma type accounted for 28.1%; the mucinous adenocarcinoma type accounted for 8.8%; the mixed adenocarcinoma type accounted for 22.8%; and some rare types accounted for 1.8%. Most cases were primarily distributed into two groups: poorly differentiated and moderately differentiated, with proportions of 62.95% and 35.1%, respectively. No cases were found in the non-differentiated and highly differentiated groups. Primarily, tumors in stages pT3 and pT4 accounted for 77.2%, with stage pT3 making up 35.1% and pT4 42.1%. Conclusion: A larger sample size is needed to further strengthen the research results obtained regarding the expression of Vimentin (epithelial-mesenchymal transition) related to histological type, histological grade, and tumor invasion depth.
CHARACTERISTICS OF THE EXPRESSION PATTERN OF VIMENTIN IN RELATION TO HISTOLOGICAL TYPE, HISTOLOGICAL GRADE, AND PT STAGE OF GASTRIC ADENOCARCINOMA AT HANOI MEDICAL UNIVERSITY HOSPITAL IN 2022-2023
27
Views
0
Downloads
Keywords
Stomach cancer, Vimentin imprint.
Abstract
References
[1]
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71:209–249. DOI: 10.3322/caac.21660
Google Scholar
[2]
Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Piñeros M, Znaor A, Bray F. Cancer statistics for the year 2020: An overview. Int J Cancer. DOI: 10.1002/ijc.33588
Google Scholar
[3]
H.S. Ryu et al (2012). Combination of epithelial-mesenchymal transition and cancer stem cell-like phenotypes has independent prognostic value in gastric cancer. Hum. Pathol. DOI: 10.1016/j.humpath.2011.07.003
Google Scholar
[4]
M. Brzozowa et al (2015). The aberrant overexpression of vimentin is linked to a more aggressive status in tumours of the gastrointestinal tract Prz. Gastroenterol. doi: 10.5114/pg.2014.47502
Google Scholar
[5]
M.E. Kidd et al (2014). The role of vimentin intermediate filaments in the progression of lung cancer Am. J. Respir. Cell Mol. Biol. DOI: 10.1165/rcmb.2013-0314TR
Google Scholar
[6]
Zhao W, Yue L, Zhou F, et al. Clinical significance of vimentin expression and Her-2 status in patients with gastric carcinoma. Clin Transl Sci. 2013;6(3):184–190. DOI: 10.1111/cts.12043
Google Scholar
[7]
Trương Thị Hoàng Lan (2013) Nghiên cứu đặc điểm mô bệnh học và sự bộc lộ một số dấu ấn hóa mô miễn dịch trong ung thư biểu mô dạ dày, luận văn thạc sĩ y học. Trường Đại học Y Hà Nội. Hà Nội.
Google Scholar
[8]
Trịnh Thị Hoa (2009), Đánh giá hiệu quả của hóa trị bổ trợ ECX trên bệnh nhân ung thư biểu mô tuyến dạ dày sau phẫu thuật tại bệnh viện K (2006-2009), luận văn thạc sĩ y học. Trường Đại học Y Hà Nội, Hà Nội.
Google Scholar